People · Operator
Named in public records as an officer, director or promoter · active 2020–2022 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Avicanna Inc. | — | Pharmaceuticals | Series A | $9.9M | $24.3M | 2020 |
Aras Azadian at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Aras Azadian on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Benjamin Leavenworth | 1 | 2 |
| Eileen McCormack | 1 | 2 |
| Flavio Zaclis | 1 | 2 |
| Dave Sohi | 1 | 1 |
| Dr. Assad Kazeminy | 1 | 1 |
| Chandrakant Panchal | 1 | 1 |
| Dr. Chandrakant Panchal | 1 | 1 |
| Amza Ali | 1 | 1 |
| Setu Purohit | 1 | 1 |
| Davender Sohi | 1 | 1 |
| Lucas Nosiglia | 1 | 1 |
| David Allan White | 1 | 1 |
| Janet Gieesselman | 1 | 1 |
| Giancarlo Davila Char | 1 | 1 |
| John McVicar | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.